SCHEMBL19170403

SCHEMBL19170403

CC(C)(O)CNC(=O)CN

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.38
CNR1 P21554 6/20 0.36
CNR2 P34972 6/20 0.36
TRPA1 O75762 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
CFTR P13569 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
RECQL P46063 1/20 0.33
SMYD3 Q9H7B4 1/20 0.32
PPARG P37231 2/20 0.32
PPARD Q03181 2/20 0.32
PPARA Q07869 2/20 0.32
MAPK1 P28482 1/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
MMP2 P08253 1/20 0.31
LMNA P02545 1/20 0.31
FUCA1 P04066 1/20 0.30
AOC3 Q16853 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL19136761 0.98 PIK3CD (0.36) PIK3CDCNR1CNR2TRPA1TRPV1
SCHEMBL993141 0.83 CACNA1H (0.35) CYP1A2CYP3A4RECQLSMYD3MAPK1
SCHEMBL26324598 0.79 CACNA1H (0.33) CYP1A2CYP3A4RECQLSMYD3MAPK1
SCHEMBL23341003 0.79 CYP1A2 (0.32) CYP1A2CYP3A4RECQLSMYD3MAPK1
SCHEMBL12947998 0.78 MEN1 (0.48) PIK3CDCNR1CNR2TRPA1TRPV1
SCHEMBL18293043 0.77 CA1 (0.34) CA1CA2MMP2AOC3
SCHEMBL18990202 0.76 PIK3CD (0.38) PIK3CDCNR1CNR2TRPA1TRPV1
SCHEMBL22833656 0.76 ALDH1A1 (0.46) PIK3CDCNR1CNR2TRPA1TRPV1
SCHEMBL18628615 0.76 PIK3CD (0.38) PIK3CDCNR1CNR2TRPA1TRPV1
SCHEMBL19169440 0.76 HPGD (0.43) PIK3CDCNR1CNR2TRPA1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119841829-A Compounds for the treatment of PI3K gamma mediated diseases and uses thereof 中国科学院合肥物质科学研究院 2025-04-18 CN disclosed
EP-3407716-B9 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2021-07-14 EP disclosed
EP-3407716-B1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO DOW AGROSCIENCES LLC (US) 2021-02-17 EP disclosed
US-10251394-B2 Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto DOW AGROSCIENCES LLC (US) 2019-04-09 US disclosed
WO-2017132015-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO DOW AGROSCIENCES LLC (US) 2017-08-03 WO disclosed
US-20170208803-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO DOW AGROSCIENCES LLC (US) 2017-07-27 US disclosed
US-20170208803-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO DOW AGROSCIENCES LLC (US) 2017-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170208803-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO ACHE, DDT, MSMO1 PIK3CD 9/4885CNR1 2830/4885CNR2 2322/4885
US-10251394-B2 Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto ACHE, DDT, MSMO1 PIK3CD 9/4885CNR1 2830/4885CNR2 2322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.